First American Bank Astrazeneca PLC Transaction History

First American Bank

$1.39 Trillion
Q3 2024

A detailed history of First American Bank transactions in Astrazeneca PLC stock. As of the latest transaction made, First American Bank holds 19,223 shares of AZN stock, worth $1.26 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

19,223

Previous 21,563 10.85%

Holding current value

$1.26 Million

Previous $1.68 Billion 10.94%

% of portfolio

0.11%

Previous 0.13%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$76.67 - $87.62 $179,407 - $205,030	-2,340 Reduced 10.85%	19,223 $1.5 Billion
Q2 2024 Jul 30, 2024	BUY	$66.81 - $80.83 $1.44 Million - $1.74 Million	21,563 New	21,563 $1.68 Billion
Q1 2024 Jul 31, 2024	BUY	$61.03 - $69.57 $372,038 - $424,098	6,096 Added 47.55%	18,915 $1.28 Million
Q4 2023 Jul 31, 2024	SELL	$61.89 - $69.28 $2.93 Million - $3.28 Million	-47,369 Reduced 78.7%	12,819 $863,000
Q3 2023 Jul 31, 2024	BUY	$64.85 - $71.7 $34,240 - $37,857	528 Added 0.89%	60,188 $4.08 Million
Q2 2023 Jul 31, 2024	SELL	$69.91 - $75.81 $19,155 - $20,771	-274 Reduced 0.46%	59,660 $4.27 Million
Q1 2023 Jul 31, 2024	SELL	$63.15 - $71.6 $491,559 - $557,334	-7,784 Reduced 11.49%	59,934 $4.16 Million
Q4 2022 Jul 31, 2024	SELL	$54.21 - $70.44 $470,488 - $611,348	-8,679 Reduced 11.36%	67,718 $4.59 Million
Q3 2022 Jul 31, 2024	SELL	$53.02 - $135.75 $417,373 - $1.07 Million	-7,872 Reduced 9.34%	76,397 $4.19 Million
Q2 2022 Jul 31, 2024	BUY	$59.26 - $71.14 $660,867 - $793,353	11,152 Added 15.25%	84,269 $5.57 Million
Q1 2022 Jul 31, 2024	BUY	$55.72 - $67.12 $2.87 Million - $3.46 Million	51,554 Added 239.09%	73,117 $4.85 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First American Bank, based on Form 13F filings with the SEC.

News

Stay updated on First American Bank with notifications on news.

Account

First American Bank Astrazeneca PLC Transaction History